Histocompatibility

• 

  Subject Areas on Research

  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A pilot study in sub-SMAS face transplantation: defining donor compatibility and assessing outcomes in a cadaver model. 
  • Accelerated rejection of skin grafts in recipients sensitized with extracted human histocompatibility antigens. 
  • Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation. 
  • Allele assignment for HLA-A, -B, and -C genes to the Tenth International Histocompatibility Workshop cell lines. 
  • Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients. 
  • Anomalous MLR responsiveness among siblings. 
  • Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. 
  • Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement. 
  • Bone marrow and thymus transplantation in ataxia-telangiectasia. 
  • Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes. 
  • Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. 
  • Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. 
  • Comparisons of mixed leukocyte reactions with skin graft survival in families genotyped for HL-A. 
  • Complement-mediated vasoconstriction and graft rejection. 
  • Cytotoxicity reactions of chimpanzee antisera with human lymphocyte donors phenotyped or genotyped for HL-A. 
  • Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Eighth Annual International Umbilical Cord Blood Transplantation Symposium, San Francisco, California, June 3-5, 2010. 
  • Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. 
  • Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. 
  • Exfoliative cytopathologic studies in organ transplantation. 3. The cytologic profile of urine during acute renal allograft rejection. 
  • Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. 
  • Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. 
  • Haploidentical transplantation for leukemia. 
  • Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. 
  • Histocompatibility and liver transplantation. 
  • Histocompatibility testing and mixed lymphocyte culture responses in chimpanzee families. 
  • Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs. 
  • IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients. 
  • Immunogenetics and immunology in transplantation. 
  • Immunological mechanisms of allograft rejection. 
  • Immunological studies on eluates from human renal allografts. 
  • Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade. 
  • Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. 
  • Incompatible bone-marrow transplantation in lymphopenic immunologic deficiency. Circumvention of fatal graft-versus-host disease by immunologic enhancement. 
  • Joint report of first histocompatibility workshop on primates. 
  • Living-related lobar lung transplantation. 
  • Living-unrelated renal donor transplantation: the UNOS experience, 1987-1991. United Network for Organ Sharing. 
  • Lung Transplantation and the Era of the Sensitized Patient. 
  • Lymphopenic immunologic deficiency in identical twins: lymphocyte allografting and graft-versus-host disease following treatment with albumin-gradient-separated paternal bone marrow cells. 
  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? 
  • Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. 
  • Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. 
  • Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. 
  • Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells. 
  • Non-specific and specific active immunotherapy in a B16 murine melanoma system. 
  • Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review. 
  • Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells. 
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. 
  • Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. 
  • Perspective: research highlights at the Duke University center for AIDS research. Immunoreconstitution in HIV infection: the role of the thymus. 
  • Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. 
  • Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. 
  • Predictive factors for immunologic graft failure in cadaver renal transplant recipients. 
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. 
  • Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules. 
  • Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. 
  • Quantifying renal allograft loss following early antibody-mediated rejection. 
  • Reactions of human HL-A sera with orangutan and gorilla lymphocytes. 
  • Renal allografts in HL-A matched recipients. Light, immunofluorescence and electron microscopic studies. 
  • Renal transplantation between histocompatible donor-recipient pairs. 
  • Renal transplantation in the American black. 
  • Results of the cord blood transplantation (COBLT) study unrelated donor banking program. 
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. 
  • Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. 
  • Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. 
  • Severe combined immunodeficiency with natural killer-cell predominance: abrogation of graft-versus-host disease and immunologic reconstitution with HLA-identical bone marrow cells. 
  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. 
  • Skin graft rejection between subjects genotyped for HL-A. 
  • State of the art in umbilical cord transplantation. 
  • Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. 
  • Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. 
  • Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. 
  • Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. 
  • Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. 
  • The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients. 
  • The immunogenicity of human HL-A haplotypesas measured by skin graft survival times and mixed leukocyte reactions. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. 
  • The management of chronic graft-versus-host disease. 
  • The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients. 
  • The pathophysiology and treatment of graft-versus-host disease. 
  • The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. 
  • Therapeutic strategies for xenograft rejection. 
  • Tissue antigens of man and chimpanzees; their role in xenografting. 
  • Tolerance and the "Holy Grail" of transplantation. 
  • Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. 
  • Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. 
  • Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. 
  • Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature. 
  • Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. 
  • Understanding the impact of HLA molecular mismatch in solid organ transplantation: Are we there yet? 
  • Unique aspects of rejection and tolerance in liver transplantation. 
  • Unmanipulated or CD34 selected haplotype mismatched transplants. 
  • Unrelated donor marrow transplantation in children. 
  • Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.